Somme Institute

seeing is believing the next time a skin care company tells you they have a "clinical breakthrough" ask them where's the proof here's ours mdt5™ the 1st approved non-prescription drug in clinical studies for the treatment of facial skin "used in clinical studies in the first randomized, double-blind, placebo-controlled clinical study demonstrating highly statistically significant improvement for the treatment of fine lines and wrinkles, acne and sun damaged skin." - michael holick, m.d., ph.d., boston university school of medicine mdt5™ is a double-patented trans-epidermal delivery system based on an aggregation of potent, stabilized re-engineered vitamins. "not since the introduction of renova has there been a more significant advancement in the science of skin care." - aaron b. lerner m.d., yale university